Literature DB >> 33834362

Development of an Integrated Optical Sensor for Determination of β-Hydroxybutyrate Within the Microplatform.

Utku Devamoglu1, Irem Duman1, Ecem Saygili1, Ozlem Yesil-Celiktas2.   

Abstract

Ketone bodies (acetoacetate, beta-hydroxybutyrate (βHB), acetone) are generated as a result of fatty acid oxidation in the liver and exist at low concentrations in urine and blood. Elevated concentrations can indicate health problems such as diabetes, childhood hypoglycemia, alcohol, or salicylate poisoning. Development of portable and cost-effective bedside point-of-care (POC) tests to detect such compounds can help to reduce the risk of disease progression. In this study, βHB was chosen as a model molecule for developing an optical sensor-integrated microplatform. Prior to sensor optimization, βHB levels were measured at a concentration range of 0.02 and 0.1 mM spectrophotometrically, which is far below the reported elevated ranges of 1-2 mM and resulting absorbance changes were converted into an Arduino microcontroller code for the correlation. Measurements performed with the designed integrated microplatform were found significant. Integrated microplatform was verified with the benchtop spectrophotometer. Measurements between 0.02 and 0.1 mM substrate concentration were found highly sensitive with "y = 0.7347x + 0.00184" with R2 value of 0.9796, and the limit of detection was determined as 0.02 mM. Based on these results, the proposed system will allow on-site and early intervention.

Entities:  

Keywords:  Ketone bodies; Microplatform; Optical sensor; Point-of-care tests

Year:  2021        PMID: 33834362     DOI: 10.1007/s12010-021-03563-3

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  18 in total

Review 1.  The future point-of-care detection of disease and its data capture and handling.

Authors:  Natalia Lopez-Barbosa; Jorge D Gamarra; Johann F Osma
Journal:  Anal Bioanal Chem       Date:  2016-01-15       Impact factor: 4.142

Review 2.  Point-of-care testing of proteins.

Authors:  Axel Warsinke
Journal:  Anal Bioanal Chem       Date:  2009-01-07       Impact factor: 4.142

3.  A Paper-Based "Pop-up" Electrochemical Device for Analysis of Beta-Hydroxybutyrate.

Authors:  Chien-Chung Wang; Jonathan W Hennek; Alar Ainla; Ashok A Kumar; Wen-Jie Lan; Judy Im; Barbara S Smith; Mengxia Zhao; George M Whitesides
Journal:  Anal Chem       Date:  2016-05-31       Impact factor: 6.986

4.  Smartphone-Powered Electrochemical Dongle for Point-of-Care Monitoring of Blood β-Ketone.

Authors:  Jinhong Guo
Journal:  Anal Chem       Date:  2017-08-23       Impact factor: 6.986

Review 5.  Physiological roles of ketone bodies as substrates and signals in mammalian tissues.

Authors:  A M Robinson; D H Williamson
Journal:  Physiol Rev       Date:  1980-01       Impact factor: 37.312

6.  Paper-based microfluidic devices for analysis of clinically relevant analytes present in urine and saliva.

Authors:  Scott A Klasner; Alexander K Price; Kurt W Hoeman; Rashaun S Wilson; Kayla J Bell; Christopher T Culbertson
Journal:  Anal Bioanal Chem       Date:  2010-04-28       Impact factor: 4.142

7.  Bedside monitoring of blood beta-hydroxybutyrate levels in the management of diabetic ketoacidosis in children.

Authors:  Arleta Rewers; Kim McFann; H Peter Chase
Journal:  Diabetes Technol Ther       Date:  2006-12       Impact factor: 6.118

Review 8.  Role of beta-hydroxybutyric acid in the central regulation of energy balance.

Authors:  Thomas Laeger; Cornelia C Metges; Björn Kuhla
Journal:  Appetite       Date:  2010-04-21       Impact factor: 3.868

9.  Quantitative determination of H2O2 for detection of alanine aminotransferase using thin film electrodes.

Authors:  Ecem Saygili; Beyza Orakci; Melisa Koprulu; Alper Demirhan; Esra Ilhan-Ayisigi; Yalin Kilic; Ozlem Yesil-Celiktas
Journal:  Anal Biochem       Date:  2019-12-09       Impact factor: 3.365

Review 10.  β-hydroxybutyrate: much more than a metabolite.

Authors:  John C Newman; Eric Verdin
Journal:  Diabetes Res Clin Pract       Date:  2014-08-19       Impact factor: 5.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.